MarketInOut Stock Screener Log In | Sign Up

Berry Genomics Co Ltd A

SZSE • Healthcare • Diagnostics & Research • Quote as of 10/30/2026
Berry Genomics Co Ltd A stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeSZSE
Market Capitalization3,485.72 mln
Float314 mln
Earnings Date10/31/2026

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

-2.94
Likely reliable

Relative Strength

30 / 100
Underperforming

Debt / Equity

0.18
Very low leverage

Pre-Tax Margin

-22%
Deeply loss-making

ROE

-13.74
Negative

Business Description

Founded in Beijing in 2010, Berry Genomics develops and sells genetic testing products and services for medical and research use across China and several international markets. Its offerings range from prenatal DNA testing and cancer genetic screening to advanced gene sequencing equipment and laboratory tools. The company also handles large-scale data analysis and serves a broad client base that includes hospitals, universities, and research organizations across Asia, the Middle East, and Australia.

Key Fundamentals

EPS-0.70
ROE-13.74
RPS2.61
ROIC-11.31
ROA-9.15
Interest Cover-26.68
EBITDA, mln-118
EV / EBITDA-30.04
EV / EBIT-18.23
Revenue, mln929
EV / Revenue3.81

Quote Details

Last 9.21
Change -0.44 (-4.56%)
Open 9.43
Volume 35,252,700
Turnover 324,677,376
Average Volume 51,712,392

Financial Ratios

Pre-Tax Profit Margin-22
Leverage Ratio1.52
Current Ratio2.12
Price / Book2.45
Price / Tangible Book2.62
Debt / Equity0.18
Price / Sales3.75

Financial Strength

Altman Z-Score3.28
Piotroski F-Score 3 / 9
Beneish M-Score-2.94
Price to Intrinsic Value3.46
Shiller PE Ratio98.60

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -6.5% 55 / 100   
1 Month -7.99% 74 / 100   
2 Months 17.77% 94 / 100   
6 Months -5.05% 86 / 100   
1 Year -28.49% 33 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog